DK630589A - 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor-sammensaetning - Google Patents

2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor-sammensaetning Download PDF

Info

Publication number
DK630589A
DK630589A DK630589A DK630589A DK630589A DK 630589 A DK630589 A DK 630589A DK 630589 A DK630589 A DK 630589A DK 630589 A DK630589 A DK 630589A DK 630589 A DK630589 A DK 630589A
Authority
DK
Denmark
Prior art keywords
dideoxypurinnucleosid
purine nucleoside
inhibitor composition
nucleoside phosphorylase
phosphorylase inhibitor
Prior art date
Application number
DK630589A
Other languages
English (en)
Other versions
DK630589D0 (da
Inventor
Mark D Erion
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK630589D0 publication Critical patent/DK630589D0/da
Publication of DK630589A publication Critical patent/DK630589A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK630589A 1988-12-14 1989-12-13 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor-sammensaetning DK630589A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28415388A 1988-12-14 1988-12-14
US31535489A 1989-02-24 1989-02-24

Publications (2)

Publication Number Publication Date
DK630589D0 DK630589D0 (da) 1989-12-13
DK630589A true DK630589A (da) 1990-06-15

Family

ID=26962435

Family Applications (1)

Application Number Title Priority Date Filing Date
DK630589A DK630589A (da) 1988-12-14 1989-12-13 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor-sammensaetning

Country Status (10)

Country Link
EP (1) EP0374096B1 (da)
JP (1) JPH02204414A (da)
KR (1) KR900009083A (da)
AU (1) AU628113B2 (da)
CA (1) CA2005205A1 (da)
DE (1) DE58902899D1 (da)
DK (1) DK630589A (da)
IE (1) IE893991L (da)
IL (1) IL92587A (da)
NZ (1) NZ231718A (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
ATE157363T1 (de) * 1989-02-27 1997-09-15 Biocryst Pharm Inc 9-substituierte-8-unsubstituierte-9-deazaguanin
JP2619710B2 (ja) * 1989-02-27 1997-06-11 日本製紙 株式会社 ２′，３′−ジデオキシプリンヌクレオシド類の製造方法
ATE133678T1 (de) * 1990-07-04 1996-02-15 Merrell Dow Pharma 9-purinyl-phosphonsäurederivate
ES2083668T5 (es) * 1991-05-16 2001-06-16 Glaxo Group Ltd Combinaciones antiviricas que contienen analogos de nucleosido.
US5494912A (en) * 1991-06-26 1996-02-27 Merrell Pharmaceuticals Inc. 9-purinyl phosphonic acid derivitives for treating gout
CZ27399A3 (cs) * 1999-01-26 2000-08-16 Ústav Experimentální Botaniky Av Čr Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
US7557113B2 (en) 2003-08-26 2009-07-07 Teijin Pharma Limited Substituted pyrrolo[3,2-d]pyrimidine derivatives
WO2005019219A1 (ja) * 2003-08-26 2005-03-03 Teijin Pharma Limited ピロロピリミジノン誘導体
DE102006017600A1 (de) * 2006-02-09 2007-08-16 Friedel, Ruthard, Dr. Nucleosidanaloga als Genexpressionsregulatoren bei Viren
EP3010507A4 (en) * 2013-06-22 2017-06-07 Nitor Therapeutics Compositions and methods for potentiating immune response for the treatment of infectious diseases and cancer
US10729711B2 (en) 2016-08-30 2020-08-04 University of Pittsburgh—of the Commonwealth System of Higher Education Methods for treatment using small molecule potassium-sparing diuretics and natriuretics
GB201820098D0 (en) * 2018-12-10 2019-01-23 Cambridge Entpr Ltd Methods of cancer treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60126220A (ja) * 1983-12-09 1985-07-05 Otsuka Pharmaceut Factory Inc 核酸成分組成物
AU570853B2 (en) * 1985-08-26 1988-03-24 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Inhibition of infectivity and cytopathic effect of htlv-111/ lav by purine bases

Also Published As

Publication number Publication date
IL92587A0 (en) 1990-08-31
IL92587A (en) 1994-04-12
CA2005205A1 (en) 1990-06-14
KR900009083A (ko) 1990-07-02
DK630589D0 (da) 1989-12-13
DE58902899D1 (de) 1993-01-14
JPH02204414A (ja) 1990-08-14
EP0374096B1 (de) 1992-12-02
NZ231718A (en) 1992-02-25
AU4607489A (en) 1990-06-21
AU628113B2 (en) 1992-09-10
IE893991L (en) 1990-06-14
EP0374096A1 (de) 1990-06-20

Similar Documents

Publication Publication Date Title
PT526253E (pt) Analogos do nucleosido 1,3-oxatiolano
KR910002326A (ko) 치료용 뉴클레오시드
SG46383A1 (en) 1, 3-Oxathiolane nucleoside analogues
DK23489A (da) Nucleosidderivater
KR900007991A (ko) 프라이머 조성물
DK375989A (da) Purinderivater
DK630589A (da) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor-sammensaetning
NO921679L (no) Inhibitorer av purin-nukleosid-fosforylase
NZ235534A (en) 3'-azido-2',3'-dideoxy purine derivatives
EP0365849A3 (en) Novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl adenosine derivatives
OA09697A (en) Nucleoside derivatives
DE68914750D1 (de) Therapeutische Nucleoside.
DK626989D0 (da) Adenosinderivater
DK95791A (da) Nucleosidanaloge
LTIP1982A (en) 9-deazahypoxantines, useful as purine nucleoside phosphorylase inhibitors
NO891835L (no) Prodrug-former av 2',3'-didehydro-2',3'-dideoksy-nukleosider.
DK339189A (da) Purinderivater
DE69002365D1 (de) Antivirale zusammensetzung.
ZA899510B (en) 2',3'-dideoxypurine nucleoside/purine nucleoside phosphorylase inhibitor combination therapy and composition
ATE104675T1 (de) Therapeutische nucleoside.
NO921776D0 (no) Nukleosid-derivater
IE891764L (en) Nucleoside compositions
GB8925037D0 (en) Nucleoside derivatives
GB8925039D0 (en) Nucleoside derivatives
FI940103A (fi) 2',3'-deoksi-2',3'-didehydronukleosidien valmistus

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment